Earlier this month, the Centers for Medicare and Medicaid (“CMS”) released a Memorandum overviewing next steps in the federal government’s implementation of the Medicare Drug Price Negotiation Program. Though CMS has only just “set the... Read More
Drug manufacturers and patients are being negatively impacted by the increasing use of insurer copay accumulator and maximizer programs. These programs prevent manufacturer assistance, such as co-pay coupons, from being applied towards a patient's... Read More
On August 3, 2022, an Illinois federal jury returned a verdict ordering Eli Lilly & Co. (“Eli Lilly”) to pay $61 million for violations of the Federal False Claims Act (“FCA”) and adjacent state FCA laws. According to a qui tam lawsuit... Read More
Frier Levitt partner Jesse C. Dresser was quoted in a Drug Topics article, “Working With Discount Cards and Manufacturer Coupons” by Keith Loria. While prescription discount cards and manufacturer coupons have advantages for increasing the size... Read More
On September 23, 2022, the Fourth Circuit issued a per curiam opinion upholding the dismissal of a 2014 qui tam suit against Forest Laboratories, LLC while vacating both the district court and subsequent Fourth Circuit panel opinions. Although the... Read More
America spends more on prescription drugs than any other country in the world. Although most patients have some form of insurance to help offset the costs of their prescriptions, 28% of Americans currently take a prescription medication that is not... Read More
An article published in Specialty Pharmacy Continuum recounts Frier Levitt partner Jesse Dresser’s presentation at the ASHP 2022 Summer Meetings and Exhibition detailing the steps that specialty pharmacies can take to navigate the legal pitfalls... Read More
The Ninth Circuit ruled that a pharmaceutical manufacturer cannot sue a 503B compounding facility for compounding versions of its commercially available product in Nexus Pharmaceuticals, Inc v. Central Admixture Pharmacy Services (CAPS), Nexus... Read More
Pharmacy Benefit Managers (“PBMs”) regularly review network pharmacies to ensure that they are meeting terms and conditions identified in their Provider Agreements and Pharmacy Manuals. One mechanism for this review includes audits and... Read More
As previously reported, Frier Levitt filed suit against the New York Department of Health and the New York State Department of Education on behalf of an independent New York oncology practice in an effort to void the State’s new and legally... Read More
